Blue Trust’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
Other funds holding DMAC
Blue Trust's DMAC Position: Q3 2026 in Review
Blue Trust held its DiaMedica Therapeutics (DMAC) position steady in Q3 2026 at 69,122 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #439.
Blue Trust first reported a position in DMAC in Q3 2024 and has held it in 9 quarters since. 67 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.
- Blue Trust held 69,122 shares of DiaMedica Therapeutics worth $572K as of Q3 2026.
- Blue Trust left its DiaMedica Therapeutics share count unchanged in Q3 2026.
- DiaMedica Therapeutics made up 0.01% of Blue Trust's portfolio in Q3 2026, its #439 holding.
- Blue Trust first reported a position in DiaMedica Therapeutics in Q3 2024 and has held it in 9 quarters since.
- 67 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.